Sep. 29, 2022—Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.
Mar. 17, 2016—An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12.
Feb. 11, 2016—One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered.
Aug. 29, 2013—Due to a national shortage of the tuberculosis (TB) test solution Tubersol, Occupational Health will temporarily suspend routine annual skin tests, effective Sept. 1, said Patricia Kinman, MSN, FNP-BC, manager of the Vanderbilt Occupational Health Clinic
May. 30, 2013—Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response.
Apr. 11, 2013—Due to an unprecedented national shortage of the tuberculosis (TB) skin testing solution Tubersol, Vanderbilt University Medical Center has temporarily paused routine skin testing of health care workers.